The Ross procedure after previous aortic valve surgery: Propensity-weighted comparison of midterm outcomes
The Journal of Thoracic and Cardiovascular Surgery · 2026-09
DOI: 10.1016/j.jtcvs.2026.09.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2026-09. Verfasst von Arman Sarshoghi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Montreal Heart Institute, Université de Montréal, Quebec, Canada. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 19 Literaturangaben. Gefördert von: Université de Montréal.
Abstract (Originalsprache)
OBJECTIVE: We aimed to compare midterm clinical, hemodynamic, and reintervention outcomes of the Ross procedure performed in primary and reoperative settings in adults. METHODS: We analyzed 816 consecutive adults undergoing the Ross procedure at the Montreal Heart Institute between 2011 and 2025: 83 (10.2%) underwent Ross procedure after at least 1 prior aortic valve operation (redo Ross), and 733 (89.8%) underwent primary Ross. Propensity-score overlap weighting balanced 9 prespecified covariates (age, sex, New York Heart Association, left ventricular ejection fraction, bicuspid morphology, pure aortic stenosis, pure aortic regurgitation [AR], endocarditis, and preoperative AR grade). Survival was compared using overlap-weighted Kaplan-Meier curves. Reintervention was modeled with Aalen-Johansen competing-risk methods. Longitudinal echocardiographic trajectories were analyzed with weighted generalized estimating equations. RESULTS: Operative mortality was 2.4% (redo) versus 0.3% (primary, P = .054). Over a median follow-up of 5.2 years (interquartile range, 2.1-8.4), redo Ross was associated with higher all-cause mortality after overlap weighting (hazard ratio [HR], 3.92; 95% CI, 1.41-10.94; P = .009). Reintervention was numerically more frequent (HR, 2.68; 95% CI, 0.93-7.75; P = .069) but not statistically significant. The redo group exhibited a consistently larger absolute sinus of Valsalva diameter from the postoperative period through 10 years, with differing dilation rates. Freedom from autograft regurgitation ≥2+ was comparable. CONCLUSIONS: The Ross procedure can be performed safely in adults after prior aortic valve surgery. Prior surgery does not protect the autograft against progressive root dilatation in adults, supporting continued imaging surveillance irrespective of operative history.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Montreal Heart Institute, Université de Montréal, Quebec, Canada.
- Department of Cardiovascular Surgery, Mount Sinai Hospital, Icahn School of Medicine at Mount Sinai, New York, NY.
- Division of Cardiac Surgery, Montreal Heart Institute, Université de Montréal, Quebec, Canada. Electronic address: philippe.demers@icm-mhi.org.
Förderung
- Université de Montréal
Zitieren
APA
Sarshoghi, A., Ajmi, N., Noly, P. E., Poirier, N., Bernier, P. L., Ibrahim, M., El-Hamamsy, I., Bouhout, I., & Demers, P. (2026). The Ross procedure after previous aortic valve surgery: Propensity-weighted comparison of midterm outcomes. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2026.09.015
Vancouver
Sarshoghi A, Ajmi N, Noly PE, Poirier N, Bernier PL, Ibrahim M, et al. The Ross procedure after previous aortic valve surgery: Propensity-weighted comparison of midterm outcomes. The Journal of Thoracic and Cardiovascular Surgery. 2026. doi:10.1016/j.jtcvs.2026.09.015
BibTeX
@article{Sarshoghi2026,
author = {Sarshoghi, Arman and Ajmi, Nabil and Noly, Pierre-Emmanuel and Poirier, Nancy and Bernier, Pierre-Luc and Ibrahim, Marina and El-Hamamsy, Ismail and Bouhout, Ismail and Demers, Philippe},
title = {The Ross procedure after previous aortic valve surgery: Propensity-weighted comparison of midterm outcomes},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2026},
doi = {10.1016/j.jtcvs.2026.09.015}
}
EUVIMED